Mar 6, 2018 by Brian FeroldiHere's Why CommerceHub Is Skyrocketing TodayShares jump after the company announces that it has accepted a buyout offer.
Mar 4, 2018 by Brian Feroldi3 Top Winning Stocks to Buy NowLooking to buy a few stocks that have history on their side? Start with these three gems.
Mar 2, 2018 by Brian FeroldiHere's Why Nektar Therapeutics Is Soaring TodayTraders cheer after the company reports blowout quarterly results.
Mar 2, 2018 by Brian Feroldi, Dan Caplinger, and Brian Stoffel3 Top Dividend Stocks With Yields Over 4%Looking for a high yield in today's pricey market? Start your search with these three dividend gems.
Mar 1, 2018 by Brian FeroldiHorizon Global's Fourth-Quarter Woes Cause Management to Take ActionManagement is shaking things up in order to get the company back on track.
Mar 1, 2018 by Brian FeroldiHere's Why Health Insurance Innovations Is Soaring TodayTraders cheer after the company posts better-than-expected quarterly results and shares upbeat guidance.
Feb 28, 2018 by Brian FeroldiThis News Explains Mallinckrodt's Fall TodayInvestors are fleeing after SEC filings reveal that the company has received a grand jury subpoena.
Feb 28, 2018 by Brian FeroldiWhy Community Health Systems Is Sinking TodayShares swoon after the company reports a huge year-over-year decline in revenue.
Feb 27, 2018 by Brian FeroldiAppFolio Ends 2017 on a High NoteThe business-focused software company reported accelerating top-line growth in the fourth quarter.
Feb 27, 2018 by Brian FeroldiHere's Why Tenet Healthcare Is Rallying TodayShares jump after the company posts upbeat quarterly results and shares bullish guidance.
Feb 26, 2018 by Brian FeroldiHere's Why MiMedx Group Inc. Is Crashing AgainThe bloodbath continues as the company grapples with news of another investigation.
Feb 23, 2018 by Brian FeroldiAppian's Revenue Surges 50%The low-code software specialist finishes 2017 with a bang.
Feb 23, 2018 by Brian Feroldi3 Growth Stocks I'd Buy Right NowThese three growth stocks are trading on the cheap, which is why this Fool would be a happy buyer today.
Feb 23, 2018 by Brian FeroldiWhy MiMedx Group Inc. Shares Are Falling AgainThe biopharmaceutical's stock took a tumble after a Wall Street Journal article asserted that the company has been breaking the law.
Feb 23, 2018 by Brian Feroldi3 Top DNA Stocks to Consider Buying NowLooking to cash in on the genomic revolution? Take a closer look at these three stocks.
Feb 23, 2018 by Brian Feroldi, Dan Caplinger, and Brian Stoffel3 Stocks That Feel Like Microsoft in 1986Want to get in early on a few stocks that hold tremendous long-term potential? Here are three to consider.
Feb 23, 2018 by Brian Feroldi, Keith Speights, and Chuck Saletta3 Top Healthcare Stocks to Buy Right NowOur healthcare experts see Celgene, Pfizer, and Alkermes as investments worth considering today. Here's why you should, too.
Feb 22, 2018 by Brian FeroldiWhy Alkermes Is Sinking TodayShares tumble after the company receives an analyst downgrade. Here's what investors need to know.
Feb 21, 2018 by Brian FeroldiWhy TransEnterix Is Rising TodayShares rally after management gives a presentation at an investor conference. Here's what investors need to know.
Feb 20, 2018 by Brian FeroldiWhy MiMedx Group, Inc. Is Crashing TodayShares plunged after the company announced that it is delaying its earnings release date in order to conduct an accounting review.
